President and Vant Chair · Roivant Sciences Ltd. (ROIV)

Frank Torti

FY2025 is the first fiscal year CompBrief holds for Frank Torti as a named executive officer of Roivant Sciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$123,300,566

Salary $725,000Stock awards $109,338,796Bonus $8,428,000

1st of 5 named executive officers at Roivant Sciences by FY2025 total.

5 named officers on file for Roivant Sciences, FY2025

Frank Torti’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 3 equity grants, each cited to its filing
  • ROIV’s disclosed peer group of 23 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Roivant Sciences’s whole pay program stands against its peers

  • Roivant Sciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ROIV→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed July 29, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Frank Torti’s full pay file as a PDF — free

More than this page: up to 10 years of Frank’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Frank Torti compensation by year

Roivant Sciences Summary Compensation Table · the one fiscal year held
In US dollars, as Roivant Sciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$725,000
Bonus$8,428,000
Stock awards$109,338,796
Option awards$0
Non-equity incentive$0
Pension and deferred compensation$0
All other$4,808,770
Total$123,300,566

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Roivant Sciences Ltd. DEF 14A filed July 29, 2026, accession 0001140361-26-029955, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Roivant Sciences Ltd. filed document, accession 0001140361-26-029955. Every figure is read from that document and cited to the page and table it appears in. Filed July 29, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU7,700,490$213,303,573—
PSU4,199,510$116,326,427—
RSU1,469,237$40,697,865—
Option344,233—$3.85

Per the Outstanding Equity Awards at Fiscal Year-End table in Roivant Sciences Ltd.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

8 Form 4 lines since the FY2025 proxy (filed July 29, 2026)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-11-12Tax withholding—12,800$41.8512,306,950
2026-11-12Other—329,550$40.3612,382,243
2026-11-12Other—62,493$41.1312,319,750
2026-11-11Other—151,293$42.0112,711,793
2026-11-11Other—240,755$41.6312,863,086
2026-11-10Other—218,369$41.1313,103,841
2026-11-10Other—173,683$40.4313,322,210
2026-09-30Tax withholding—40,309$36.5713,495,893

The 8 most recent of 8 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Roivant Sciences’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Frank Torti · this pagePresident and Vant Chair$123,300,566
Eric VenkerPresident and Immunovant CEO$24,400,210
Richard PulikChief Financial Officer$4,190,602
Matthew GlineChief Executive Officer$3,096,190
Mayukh SukhatmePresident and Chief Investment Officer$1,276,655

The full Roivant Sciences compensation record

free company brief

This page is one person within Roivant Sciences's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Roivant Sciences proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Roivant Sciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Frank Torti's compensation dossier · One-time report. No refunds.